N-methyl-D-aspartate receptor antibody-mediated neurological disease: Results of a UK-based surveillance study in children

Archives of Disease in Childhood

Volumn 100, Issue 6, 2015, Pages 521-526

  Wright, Sukhvir ^a,b   Hacohen, Yael ^a   Jacobson, Leslie ^a   Agrawal, Shakti ^b   Gupta, Rajat ^b   Philip, Sunny ^b   Smith, Martin ^b   Lim, Ming ^a,c   Wassmer, Evangeline ^a   Vincent, Angela ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTISTREPTOLYSIN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MYCOPHENOLATE MOFETIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; OLIGOCLONAL BAND; RITUXIMAB; STEROID; AUTOANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTICONVULSANT THERAPY; ARTICLE; BEHAVIOR CHANGE; CEREBROSPINAL FLUID LEVEL; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL OUTCOME; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; FALLOT TETRALOGY; FEMALE; FOLLOW UP; HEART ARREST; HUMAN; HYPOVENTILATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INTENSIVE CARE; KARYOTYPE 47,XXX; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MYOCLONUS; MYOKYMIA; NEUROPSYCHIATRY; PLASMA EXCHANGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SCHOOL CHILD; SEIZURE; SEX RATIO; SLEEP DISORDER; STEROID THERAPY; TERATOMA; UNITED KINGDOM; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BLOOD; ENCEPHALITIS; IMMUNOLOGY; INFANT; QUESTIONNAIRE;

ADOLESCENT; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS; FEMALE; GREAT BRITAIN; HUMANS; IMMUNOTHERAPY; INFANT; MALE; PROSPECTIVE STUDIES; RECEPTORS, N-METHYL-D-ASPARTATE; SURVEYS AND QUESTIONNAIRES;

EID: 84930029489     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2014-306795     Document Type: Article

References (22)

1. Lancaster E, Dalmau J. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012;8:380-90.
2. Vincent A, Bien CG, Irani SR, et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011;10:759-72.
3. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010;133(Pt 6):1655-67.
4. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
5. Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009;66:11-18.
6. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157-65.
7. Armangue T, Titulaer MJ, Malaga I, et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 2013;162:850-6.e2.
8. Kashyape P, Taylor E, Ng J, et al. Successful treatment of two paediatric cases of anti-NMDA receptor encephalitis with cyclophosphamide: the need for early aggressive immunotherapy in tumour negative paediatric patients. Eur J Paediatr Neurol 2012;16:74-8.
9. Hacohen Y, Wright S, Waters P, et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 2013;84:748-55.
10. Hacohen Y, Dlamini N, Hedderly T, et al. N-methyl-D-aspartate receptor antibody-associated movement disorder without encephalopathy. Dev Med Child Neurol 2014;56:190-3.
11. Titulaer MJ, Höftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014;75:411-28.
12. Hacohen Y, Absoud M, Hemingway C, et al. NMDA receptor antibodies associated with distinct white matter syndromes. Neurol Neuroimmunol Neuroinflamm 2014;1:e2.
13. Goldberg EM, Titulaer M, de Blank PM, et al. Anti-N-methyl-D-aspartate receptor-mediated encephalitis in infants and toddlers: case report and review of the literature. Pediatr Neurol 2014;50:181-4.
14. Viaccoz A, Desestret V, Ducray F, et al. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 2014;82:556-3.
15. Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012;79:1094-100.
16. Hacohen Y, Deiva K, Pettingill P, et al. N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord 2014;29:90-6.
17. Armangue T, Leypoldt F, Malaga I, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 2014;75:317-23.
18. Mohammad SS, Sinclair K, Pillai S, et al. Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor. Mov Disord 2014;29:117-22.
19. Pruss H, Finke C, Holtje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012;72:902-11.
20. Dale RC, Brilot F, Duffy LV, et al. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology 2014;83:142-50.
21. Finke C, Kopp UA, Pruss H, et al. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 2012;83:195-8.
22. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010;10:835-44.